Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders
Real-world analysis showed serum phosphate reductions following XPHOZAH initiation across all phosphate binder groups evaluated
Covered in this story
Call it yourself
No calls on $ARDX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ardelyx Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.